Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03686514 · ClinicalTrials.gov registry record · Phase 4
The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
NCT03686514 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 39 participants.
The verdict
NCT03686514, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
Study Summary
The goal of this study is to understand the impact on the human immune system's response to the four strain flu vaccine in individuals who have "imprinted" on specific influenza strains. It will also consider the effects of repeated prior annual influenza vaccination on the immune system.
Interventions
- BIOLOGICAL FLUARIX QUADRIVALENT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-10-22 |
| Est. Completion | 2020-06-20 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03686514
The ClinicalTrials.gov registry entry for NCT03686514 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FLUARIX QUADRIVALENT is the first listed.
NCT03686514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03686514 about?
NCT03686514 is a clinical study titled "The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics". The goal of this study is to understand the impact on the human immune system's response to the four strain flu vaccine in individuals who have "imprinted" on specific influenza strains. It will also consider the effects of repeated prior annual influenza vaccination on the immune system.
What is the current status of trial NCT03686514?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2018-10-22. Estimated completion is 2020-06-20.
What interventions are being tested in trial NCT03686514?
The interventions under investigation include: FLUARIX QUADRIVALENT (BIOLOGICAL).
Who is sponsoring clinical trial NCT03686514?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.